NCT02351323View on ClinicalTrials.gov

Novel Type 2 Diabetes Mellitus Preventive Therapies

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Diabetes
Interventions
DRUG

Glutamine (Pharmacological doses)

30 grams/day of glutamine for 12-14 months

BEHAVIORAL

Lifestyle change

Lifestyle change as recommended by Registered Dietitian

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Medical Center

OTHER

NCT02351323 - Novel Type 2 Diabetes Mellitus Preventive Therapies | Biotech Hunter | Biotech Hunter